Processed human amniotic fluid retains its antibacterial activity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Processed human amniotic fluid retains its antibacterial activity

Published:2019-03-01 Issue:1 Volume:17 Page:
ISSN:1479-5876
Container-title:Journal of Translational Medicine
language:en
Short-container-title:J Transl Med

Author:

Mao Yong,Pierce Jan,Singh-Varma Anya,Boyer Michael,Kohn Joachim,Reems Jo-Anna

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12967-019-1812-8.pdf

Reference38 articles.

1. Silini AR, et al. The long path of human placenta, and its derivatives, in regenerative medicine. Front Bioeng Biotechnol. 2015;3:162.

2. Tyszkiewicz JT, et al. Amnion allografts prepared in the central tissue bank in Warsaw. Ann Transplant. 1999;4(3–4):85–90.

3. Stock SJ, et al. Natural antimicrobial production by the amnion. Am J Obstet Gynecol. 2007;196(3):255.

4. Underwood MA, Gilbert WM, Sherman MP. Amniotic fluid: not just fetal urine anymore. J Perinatol. 2005;25(5):341–8.

5. Bergman N, Bercovici B, Sacks T. Antibacterial activity of human amniotic fluid. Am J Obstet Gynecol. 1972;114(4):520–3.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immersed in a reservoir of potential: amniotic fluid-derived extracellular vesicles;Journal of Translational Medicine;2024-04-12

2. One-Year Results of a Phase I/II Randomized, Double-Masked, Placebo-Controlled Study of Processed Amniotic Fluid Drops After PRK;Cornea;2024-01-26

3. Enhancing Antimicrobial Activity and Reducing Cytotoxicity of Silver Nanoparticles through Gelatin Nanoparticles;Nanomedicine;2024-01-25

4. A randomized, double-blinded, placebo-controlled clinical trial of sterile filtered human amniotic fluid for treatment of COVID-19;BMC Infectious Diseases;2023-12-08

5. Phase I/II randomized, double-masked, placebo-controlled study of processed amniotic fluid drops after PRK;Journal of Cataract and Refractive Surgery;2023-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3